Sable Bio

Private

SF-based biotech building AI-designed protein degradation therapeutics for oncology.

Founders Anna Kim

CEO Anna Kim

Company

Founded

2022

Headquarters

San Francisco, United States

Financials

Total Funding

$134M

Sectors

Artificial Intelligence Biotech

sablebio.com

Funding History

3 rounds

Series B Aug 11, 2026

$80M

Flagship Pioneering (Lead) ARCH Venture Partners Third Rock Ventures

Series A Aug 20, 2024

$42M

Third Rock Ventures (Lead) ARCH Venture Partners Flagship Pioneering

Seed Feb 5, 2023

$12M

ARCH Venture Partners (Lead) Third Rock Ventures

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.